LIBERTEK

This brand name is authorized in Estonia, Lithuania

Active ingredients

The drug LIBERTEK contains one active pharmaceutical ingredient (API):

1 Roflumilast
UNII 0P6C6ZOP5U - ROFLUMILAST

Roflumilast is a PDE4 inhibitor, a non-steroid, anti-inflammatory active substance designed to target both the systemic and pulmonary inflammation associated with COPD.

Read about Roflumilast

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R03DX07 Roflumilast R Respiratory system → R03 Drugs for obstructive airway diseases → R03D Other systemic drugs for obstructive airway diseases → R03DX Other systemic drugs for obstructive airway diseases
Discover more medicines within R03DX07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1518757, 1518768, 1518779
Country: LT Valstybinฤ— vaistลณ kontrolฤ—s tarnyba Identifier(s): 1059257, 1059258, 1059259

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈